Northeast Pharmaceutical Group (东北制药集团股份有限公司) is the former Northeast General Pharmaceutical Factory, which was established in 1946. More than 70 years later, Northeast Pharmaceutical Group employs 9,300 people and has assets of 9.76 billion yuan ($1.47 billion). a State-owned comprehensive pharmaceutical enterprise, Northeast Pharmaceutical Group now generates nearly 5 billion yuan in annual sales revenue with annual export revenue reaching 100 million yuan. The group was listed on the Shenzhen Stock Exchange in 1996.
China's key base for pharmaceutical production and export, Northeast Pharmaceutical Group incorporates a medical research institute, design institute and a quality inspection center. Its postdoctoral research center brings together top professionals and management personnel to form an integrated system for scientific research, production, operation and training, ensuring the group maintains a strong ability to develop new drugs and technologies.
The group manufactures pharmaceuticals used in anti-infective system treatment, gynecology and obstetrics, the digestive system, urinary system, antiviral treatments, and in heart and cerebral vessels. It also produces more than 400 types of chemical-based raw medicines, medical intermediates and preparation products. Its leading products are exported to more than 100 countries and regions.
Logo of Northeast Pharmaceutical Group
Official website: http://www.nepharm.com.cn/